E82K (p.Glu82Lys) variant of SERPINC1 (Antithrombin-III)

E82K (p.Glu82Lys) in SERPINC1 (Antithrombin-III) is a missense change. Clinical records from EBI and UniProt describe it as likely pathogenic. The available variant effect predictions contribute to a CATVariant prioritization score of 0.70 / 1. The record also includes population frequency data and structural context.

E82K (p.Glu82Lys) variant details